Pediatric Dermatology

Pediatric Rosacea

Author and Disclosure Information

 

References

Rosacea is a clinical diagnosis but biopsy can be performed to rule out other diagnoses. Treatment consists of lifestyle modifications such as avoiding known triggers and the use of topical and/or oral agents. Common topical therapies include metronidazole and erythromycin. Systemic antibiotics include tetracycline, doxycycline, minocycline, azithromycin, and erythromycin. Some children are able to taper systemic agents and maintain disease control with topical therapy, while others may need to continue a low-dose antibiotic. Although flares can be controlled within weeks to months, rosacea is a chronic disorder and childhood rosacea tends to persist into adulthood.

Pages

Recommended Reading

Rash, microcephaly not always present with congenital Zika syndrome
MDedge Dermatology
Ustekinumab misses primary endpoint in atopic dermatitis
MDedge Dermatology
T-VEC plus ipilimumab safe, effective in advanced melanoma
MDedge Dermatology
Significant race and health care disparities exist among hospitalized psoriasis patients
MDedge Dermatology
Hidradenitis Suppurativa Video Roundtable
MDedge Dermatology
Analysis supports daily folate for children with psoriasis on methotrexate
MDedge Dermatology
Multisite NIH-sponsored research can now use single IRB
MDedge Dermatology
Zika Understanding Unfolds
MDedge Dermatology
Supreme Court will not hear pharmacy religious liberty case
MDedge Dermatology
Case series describes melanoma-associated leukoderma presenting as atypical vitiligo
MDedge Dermatology